Last reviewed · How we verify

NEPA — Competitive Intelligence Brief

NEPA (NEPA) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pain.

marketed Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase Pain Small molecule Live · refreshed every 30 min

Target snapshot

NEPA (NEPA) — Harrow Eye.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
NEPA TARGET NEPA Harrow Eye marketed Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase
Zomiperac ZOMEPIRAC marketed zomepirac Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase 1980-01-01
DERACOXIB DERACOXIB marketed Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein
Xibrom Xibrom Bp Consulting, Inc marketed Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase
Nevanac Nevanac Santa Casa de Misericordia de Santos marketed Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase
Yellox Yellox University of Trieste phase 3 Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). NEPA — Competitive Intelligence Brief. https://druglandscape.com/ci/nepa. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: